Giulia Degiacomi

1.6k total citations
35 papers, 829 citations indexed

About

Giulia Degiacomi is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Giulia Degiacomi has authored 35 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 17 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Giulia Degiacomi's work include Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (15 papers) and Biochemical and Molecular Research (10 papers). Giulia Degiacomi is often cited by papers focused on Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (15 papers) and Biochemical and Molecular Research (10 papers). Giulia Degiacomi collaborates with scholars based in Italy, France and Russia. Giulia Degiacomi's co-authors include Maria Rosalia Pasca, Laurent R. Chiarelli, Josè Camilla Sammartino, Francesca Boldrin, Riccardo Manganelli, Vadim Makarov, Stewart T. Cole, Giovanna Riccardi, Olga Riabova and Jana Korduláková and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Giulia Degiacomi

34 papers receiving 823 citations

Peers

Giulia Degiacomi
Juan M. Belardinelli United States
Mary Ann DeGroote United States
Shiva K. Angala United States
Venkata M. Reddy United States
Thulasi Warrier United States
Veeraraghavan Usha United Kingdom
Giulia Degiacomi
Citations per year, relative to Giulia Degiacomi Giulia Degiacomi (= 1×) peers Romain Veyron‐Churlet

Countries citing papers authored by Giulia Degiacomi

Since Specialization
Citations

This map shows the geographic impact of Giulia Degiacomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Degiacomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Degiacomi more than expected).

Fields of papers citing papers by Giulia Degiacomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Degiacomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Degiacomi. The network helps show where Giulia Degiacomi may publish in the future.

Co-authorship network of co-authors of Giulia Degiacomi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Degiacomi. A scholar is included among the top collaborators of Giulia Degiacomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Degiacomi. Giulia Degiacomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabodoarivelo, Marie Sylvianne, Eik Hoffmann, Cyril Gaudin, et al.. (2025). Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis. STAR Protocols. 6(1). 103643–103643. 3 indexed citations
2.
Boldrin, Francesca, Giulia Degiacomi, Riccardo Manganelli, et al.. (2025). Cord blood innate-like T cell responses in neonates born to healthy women and women living with HIV. Frontiers in Immunology. 16. 1628145–1628145.
3.
Hoffmann, Pascal, Nathalie Saffon‐Merceron, Frédéric Rodriguez, et al.. (2024). Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis. Molecules. 29(13). 3076–3076. 3 indexed citations
4.
Stelitano, Giovanni, et al.. (2023). Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. International Journal of Molecular Sciences. 24(5). 4635–4635. 17 indexed citations
5.
Degiacomi, Giulia, Giovanni Stelitano, Vadim Makarov, et al.. (2023). CanB, a Druggable Cellular Target in Mycobacterium tuberculosis. ACS Omega. 8(28). 25209–25220. 3 indexed citations
6.
Mulyukin, A. L., et al.. (2023). Distinct Effects of Moxifloxacin and Bedaquiline on Growing and ‘Non-Culturable’ Mycobacterium abscessus. Microorganisms. 11(11). 2690–2690. 5 indexed citations
7.
Wijk, Rob C. van, Ainhoa Lucía, Cyril Gaudin, et al.. (2023). Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium. iScience. 26(4). 106411–106411. 3 indexed citations
8.
Bijani, Christian, Laure Vendier, Sandrine Cojean, et al.. (2023). Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities. Molecules. 28(13). 5284–5284. 4 indexed citations
9.
Zanettini, Claudio, Modupe O. Coker, Sarah Boudová, et al.. (2023). Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential. Cellular Immunology. 395-396. 104797–104797. 4 indexed citations
10.
Degiacomi, Giulia, Giovanni Stelitano, Josè Camilla Sammartino, et al.. (2022). The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme. International Journal of Molecular Sciences. 23(2). 771–771. 15 indexed citations
11.
Sammartino, Josè Camilla, et al.. (2022). Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex. Biochemical and Biophysical Research Communications. 607. 49–53. 8 indexed citations
12.
Ferlenghi, Francesca, Giannamaria Annunziato, Giulia Degiacomi, et al.. (2022). Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization. European Journal of Medicinal Chemistry. 245(Pt 2). 114916–114916. 9 indexed citations
13.
Chiarelli, Laurent R., et al.. (2020). Nitric oxide-releasing compounds for the treatment of lung infections. Drug Discovery Today. 26(2). 542–550. 12 indexed citations
14.
Mori, Giorgia, Béatrice Silvia Orena, Laurent R. Chiarelli, et al.. (2020). Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug. Frontiers in Microbiology. 11. 292–292. 7 indexed citations
15.
Boudová, Sarah, Titus Divala, Randy G. Mungwira, et al.. (2020). Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy. Cellular Immunology. 359. 104244–104244. 11 indexed citations
16.
Rodriguez, Frédéric, N. Saffon, Josè Camilla Sammartino, et al.. (2019). First triclosan-based macrocyclic inhibitors of InhA enzyme. Bioorganic Chemistry. 95. 103498–103498. 22 indexed citations
17.
Degiacomi, Giulia, Michael Zimmermann, Alessandro Cascioferro, et al.. (2017). PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis. PLoS Pathogens. 13(5). e1006399–e1006399. 78 indexed citations
18.
Degiacomi, Giulia, Andrej Benjak, Jan Madacki, et al.. (2017). Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression. Scientific Reports. 7(1). 43495–43495. 92 indexed citations
19.
Degiacomi, Giulia, Yoann Personne, Guillaume Mondésert, et al.. (2016). Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis. Tuberculosis. 100. 95–101. 31 indexed citations
20.
Ribeiro, Ana, Giulia Degiacomi, Fanny Ewann, et al.. (2011). Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis. PLoS ONE. 6(11). e26675–e26675. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026